Chemokine-independent in vitro resistance to human immunodeficiency virus (HIV-1) correlating with low viremia in long-term and recently infected HIV-1-positive persons

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1168-1174

  Schwartz, David H ^a   Castillo, Renan C ^a   Arango Jaramillo, Silvio ^a   Sharma, Usha K ^a   Song, Hai Feng ^a,c   Sridharan, Gopalan ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; VIREMIA; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0030773736     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514109     Document Type: Article

References (14)

1. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-9.
2. D'Souza MP, Mathieson BJ. Meeting report: early phases of HIV type 1 infection. AIDS Res Hum Retroviruses 1996;12:1-9.
3. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
4. Wong MT, Dolan MJ, Kozlow E, et al. Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J Infect Dis 1996;173:877-87.
5. Hogervost E, Jrriaans S, de Wolf F, et al. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific antibody levels. J Infect Dis 1995;171:811-21.
6. + lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334:426-31.
7. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
8. Cao YZ, Qin L, Zhang L, Safrit JT, Ho DD. Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
9. Rinaldo CR Jr, Huang X, Fan Z, et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of dis ease in HIV-1-infected long-term nonprogressors. J Virol 1995;69:5838-42.
10. Michael N, Chang G, d'Arcy L, et al. Evidence for defective accessory genes in an HIV-1 infected long-term survivor without recoverable virus. J Virol 1995;69:4228-36.
11. Deacon NJ, Tsykin A, Solmon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-91.
12. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-32.
13. Ometto L, Zanotto C, Maccabrani A, et al. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 1995;9:427-34.
14. Lederman MM, Jackson JB, Kroner BL, et al. Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs. J Infect Dis 1995;172:228-31.